A lung cancer molecular prognostic test ready for prime time

A lung cancer molecular prognostic test ready for prime time

[...] the signature works for nonsquamous lung cancers, meaning that a squamous-cell lung cancer and other non-adenocarcinoma variants must fi rst be ruled out by pathology.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Lancet (British edition) 2012-03, Vol.379 (9818), p.785-787
Hauptverfasser: Xie, Yang, Minna, John D
Format: Artikel
Sprache:eng
Schlagworte:
Cancer therapies
Carcinoma, Non-Small-Cell Lung - mortality
Clinical medicine
Female
Humans
Internal Medicine
Lung cancer
Lung Neoplasms - mortality
Male
Multivariate analysis
Polymerase Chain Reaction
Statistical methods
Stem cells
Studies
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[...] the signature works for nonsquamous lung cancers, meaning that a squamous-cell lung cancer and other non-adenocarcinoma variants must fi rst be ruled out by pathology.
ISSN:0140-6736
1474-547X
DOI:10.1016/S0140-6736(12)60154-8